SMS Pharmaceuticals Ltd.

₹374.65

-22 (-5.5%)

SMSPHARMA Share Price

Pharmaceuticals & Biotechnology

As on July 30, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 3,519 Cr

P/E Ratio48.04

Dividend Yield0.11 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	385.01	Bearish
10-DMA	385.66	Bearish
20-DMA	395.68	Bearish
50-DMA	386.86	Bearish
100-DMA	393.32	Bearish
200-DMA	353.62	Bullish

Historical Performance

1 Year

58%

3 Years

221.5%

5 Years

114.2%

10 Years

291.5%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	7,827	7,093	5,221	5,199	5,632
Total Expenditure	6,438	5,925	4,675	4,053	4,420
Other Income	62	45	49	52	35
Operating Profit	1,452	1,212	594	1,198	1,246
Interest	185	236	220	192	112
Depreciation	343	315	321	322	223
Profit Before Tax	923	661	53	685	911
Consolidated Net Profit	691	498	-71	622	625
Adjusted EPS	8	6	-1	7	7

Compounded Sales Growth

10 Years:5.3

5 Years:13.7

3 Years:8.5

TTM:2

Compounded Profit Growth

10 Years:11.1

5 Years:17

3 Years:2.1

TTM:6.8

Stock Price CAGR

10 Years:14.6

5 Years:16.5

3 Years:46.9

TTM:60

Return on Equity

10 Years:4.8

5 Years:7.4

3 Years:-0.8

last year:7.8

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	89	85	85	85	85
Total Reserves	6,149	4,993	4,521	4,618	4,021
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	1,887	1,660	1,642	1,927	2,063
Other Current Liabilities	845	654	527	547	583
Short Term Borrowings	1,248	1,140	938	679	709
Total Liabilities	11,728	10,491	8,797	8,745	8,282
Capital Work in Progress	347	303	332	110	67
Long Term Loans & Advances	159	190	107	93	91
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	366	360	254	394	386
Total Current Assets	5,746	5,489	4,107	3,921	3,253
Total Assets	11,728	10,491	8,797	8,745	8,282
Adjusted Book Value	70	60	54	56	48

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 48.04, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 46.9%, indicating sustained price appreciation.
The stock carries a high beta of 1.3, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹1452 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹7827 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1599018.4

No. of Shares: 4268 (Approx)

Performance:59.9%

599018.4

NIFTY Performance: -1.8%

1 day Top Gainers